YOLFTbeta
TerrAscend Corp.

TerrAscend Corp.

TSND · TO · Healthcare / Drug Manufacturers - Specialty & Generic

0.54CAD-0.04 (-6.90%)

Price History

Full chart

Market Stats

Previous Close0.58
Open0.60
Day Range0.54 – 0.60
52-Week Range0.53 – 2.00
Volume216.96K
Market Cap275.77M
P/E (TTM)0.00
Forward P/E138.89
EPS-0.15
Dividend Yield0.00%
Beta2.17
50-Day Avg0.8357
200-Day Avg0.9144

About

TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States. The company manufactures vaporizables, concentrates, topicals, flowers, tinctures, and edibles. It offers its products under the brand name Kind Tree Cannabis, Legend, Valhalla Confections, State Flower Cannabis, Ilera Healthcare, Wana, and Cookies. The company also operates retail dispensaries under the Apothecarium brand name. It serves medical patients and adult-use consumers in North America. The company was incorporated in 2017 and is headquartered in Mississauga, Canada.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Ziad Ghanem
  • Employees828
  • Headquarters77 City Centre Drive, East Tower, Mississauga, ON, Canada, L5B 1M5, Canada
  • Websitehttps://www.terrascend.com

Leadership

  • Mr. Jason Garrett Wild R.Ph.Executive Chairman · b. 1973
  • Mr. Ziad GhanemPresident, CEO & Director · b. 1977
  • Ms. Lynn Gefen J.D.Chief People Officer, Chief Legal Officer & Corporate Secretary · b. 1971
  • Mr. Eric JacksonChief Financial Officer
  • Ms. Alisa CampbellSVP of Corporate Finance & Accounting
  • Mr. David WheelerSenior VP & Chief Information Officer
  • Mr. BJ CarrettaSenior Vice President of Marketing
  • Michelle NelsonSenior Counsel

Financials

Income Statement

Currency: USD2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue----6.83M84.87M198.32M194.21M247.83M250.51M306.68M265.12M
Growth (%)-----+1143.31%+133.68%-2.07%+27.61%+1.08%+22.42%-13.55%
Cost of Revenue2.23K14.42K-381.32K10.17M87.52M171.98M109.32M143.56M112.49M156.72M131.93M
Gross Profit-2.23K-14.42K--381.32K-3.34M-2.65M26.34M115.97M104.27M138.02M149.96M133.19M
Gross Margin-----48.96%-3.12%13.28%59.71%42.07%55.09%48.90%50.24%
Operating Expense334.78K748.83K-6.27M24.81M62.39M75.60M93.06M127.31M102.37M167.07M87.78M
Operating Income-337.01K-763.25K-866.94K-6.66M-28.16M-65.04M-49.26M22.91M-23.04M35.64M-17.11M45.41M
Operating Margin-----412.47%-76.63%-24.84%11.80%-9.29%14.23%-5.58%17.13%
EBITDA-337.54K-763.25K-866.94K-6.56M-27.23M-149.97M-93.25M44.96M-246.52M-1.03M6.16M62.92M
EBITDA Margin-----398.97%-176.71%-47.02%23.15%-99.47%-0.41%2.01%23.73%
Net Income-337.56K-761.66K-867.18K-6.81M-22.03M-215.79M-155.12M3.11M-320.09M-91.10M-80.23M-87.74M
Net Income Margin-----322.71%-254.26%-78.22%1.60%-129.16%-36.37%-26.16%-33.09%
R&D----141.00K709.00K426.00K00---
R&D as % of Total Revenue----2.07%0.84%0.21%0.00%0.00%---
Interest Expense-----5.79M7.03M24.57M37.90M35.11M35.40M36.93M
Interest Expense % of Total Revenue-----6.82%3.55%12.65%15.29%14.01%11.54%13.93%

Balance Sheet

Currency: USD2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets382.92K539.18K3.87M69.06M88.98M460.77M603.88M581.93M701.59M666.52M607.23M566.83M
Total Liabilities720.48K1.11M1.79M1.69M31.08M385.44M592.76M352.98M380.42M425.78M430.41M467.99M
Total Equity-337.56K-568.67K2.08M67.37M56.47M66.68M1.19M223.59M318.80M242.50M176.96M97.31M
Cash59.93K99.00K3.33M51.82M21.77M11.90M75.41M79.64M26.16M22.24M26.38M37.46M
Total Debt----12.62M112.08M207.05M211.44M246.02M255.70M246.18M256.49M
Net Debt-59.93K-99.00K-3.33M-51.82M-9.15M92.07M195.71M131.79M219.86M233.46M219.80M219.03M

Cash Flow

Currency: USD2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-556.03K-514.20K-422.64K-4.15M-25.09M-47.91M33.01M-30.15M-26.12M27.47M37.95M22.07M
Investing Cash Flow--141.69K-4.27K-14.38M-21.19M-135.87M-251.60M-132.42M-27.58M-16.22M-12.25M-15.03M
Financing Cash Flow615.96K695.05K3.66M67.01M16.24M174.64M284.71M182.20M3.72M-12.50M-24.72M4.26M
Capital Expenditure0141.69K4.27K14.38M12.78M45.07M61.11M50.39M54.61M9.43M10.55M8.76M
Free Cash Flow-667.24K-655.89K-426.91K-18.53M-37.87M-92.98M-28.10M-88.82M-88.00M18.04M27.40M13.31M
FCF to OCF120.00%127.56%101.01%446.35%150.91%194.06%-85.11%294.55%336.85%65.68%72.20%60.29%

Earnings

Report DateNov 20, 2019May 28, 2020Aug 18, 2020Nov 19, 2020May 19, 2021Aug 19, 2021Nov 16, 2021May 12, 2022Aug 11, 2022Nov 14, 2022May 11, 2023Aug 10, 2023Nov 9, 2023Mar 14, 2024May 9, 2024Aug 8, 2024Nov 6, 2024Mar 6, 2025May 8, 2025Aug 7, 2025Nov 6, 2025Mar 12, 2026May 7, 2026Aug 6, 2026Nov 12, 2026
EPS Estimate-0.07-0.05-0.010.010.030.01-0.03-0.04-0.04-0.03-0.03-0.02-0.01-0.02-0.02-0.03-0.03-0.04-0.03-0.02-0.01-0.01-0.01-0.02
EPS Actual-0.23-0.07-0.040.03-0.03-0.020.68-0.08-0.03-0.03-0.06-0.04-0.03-0.16-0.04-0.04-0.07-0.11-0.04-0.16-0.030.02-0.03-0.03-
Surprise-228.57%-40.00%-200.00%-400.00%-166.67%6700.00%-166.67%25.00%25.00%-100.00%-33.33%-50.00%-1500.00%-100.00%-100.00%-133.33%-266.67%0.00%-433.33%-50.00%270.00%-200.00%-200.00%-
TimingPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap275.77M
Enterprise Value580.25M
Trailing P/E0.00
Forward P/E138.89
Price / Sales1.04
Price / Book2.66
EPS-0.15
Book Value0.36
Revenue (TTM)263.91M
Gross Profit (TTM)139.26M
EBITDA60.83M
Profit Margin-15.72%
Operating Margin18.05%
Return on Equity-26.98%
Return on Assets4.99%
Shares Outstanding309.18M
Shares Float220.67M
Beta2.17
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%